{"symbol":"ABBV","provider":"yahoo-finance","fetchedAt":"2025-12-27T20:45:00.724Z","asOfDate":"2025-12-27","articles":[{"id":"7cc9abba-3439-3e43-afa5-bfba32d7fd39","title":"Is AbbVie a Buy, Sell, or Hold in 2026?","url":"https://finance.yahoo.com/m/7cc9abba-3439-3e43-afa5-bfba32d7fd39/is-abbvie-a-buy%2C-sell%2C-or.html","publisher":"Motley Fool","publishedAt":"2025-12-27T19:50:00.000Z","relatedTickers":[],"mainIdea":"Is AbbVie a Buy, Sell, or Hold in 2026?","summary":"Motley Fool: Is AbbVie a Buy, Sell, or Hold in 2026?. It is wrapping up another great year, and there is no sign of a slowdown."},{"id":"d558a4b2-0c74-3ba9-9b62-bfd66341ea62","title":"The Best Stocks to Invest $50,000 in Right Now","url":"https://finance.yahoo.com/m/d558a4b2-0c74-3ba9-9b62-bfd66341ea62/the-best-stocks-to-invest.html","publisher":"Motley Fool","publishedAt":"2025-12-27T18:50:00.000Z","relatedTickers":["AMZN","GOOG","LLY","WMT"],"mainIdea":"The Best Stocks to Invest $50,000 in Right Now","summary":"Motley Fool: The Best Stocks to Invest $50,000 in Right Now. If you're investing for the long run, there are a myriad of companies begging to be bought. Related tickers mentioned: AMZN, GOOG, LLY, WMT."},{"id":"c230000d-df7d-376d-a470-467c6c84e11f","title":"This Cancer-Fighting Biotech Surges Into Buy Zone As Earnings Soar 131%","url":"https://finance.yahoo.com/m/c230000d-df7d-376d-a470-467c6c84e11f/this-cancer-fighting-biotech.html","publisher":"Investor's Business Daily","publishedAt":"2025-12-26T16:07:25.000Z","relatedTickers":["GMAB","GNMSF","JNJ","PFE"],"mainIdea":"This Cancer-Fighting Biotech Surges Into Buy Zone As Earnings Soar 131%","summary":"Investor's Business Daily: This Cancer-Fighting Biotech Surges Into Buy Zone As Earnings Soar 131%. Investors gave been rotating away from technology. This biotech stock has rallied into a buy zone amid sharp earnings growth. Related tickers mentioned: GMAB, GNMSF, JNJ, PFE."}]}
